from the peripheral circulation, and the animals gained in weight. But there was always a relapse, and further injections kept the disease at bay for a shorter period; and eventually there came a time when the salvarsan no longer had any effect on the parasite.
Dr. F. PARKES WEBER: Amongst the non-syphilitic diseases in the treatment of which salvarsan and neo-salvarsan have been employed, an important place must be given to diseases of the blood and bloodforming tissues. Dr. Byrom Bramwell has already dealt specially with pernicious anaemia. F. Perussia' claims a remarkably good result in a grave case of splenic anLemia. The patient was a woman, aged 30, whose general condition was thought to be too bad to justify the operation of splenectomy. Three intravenous injections of salvarsan, each of 0 3 grin., were given. The improvement which followed was so rapid that Perussia asks himself whether it was due to a general effect of arsenic on the blood-forming tissues of the body, or whether it should be regarded as a specific effect of the salvarsan on as yet unknown micro-organisms which cause the disease. There was apparently no -evidence whatever of syphilis in Perussia's case, and the blood serum gave a negative Wassermann's reaction, but it should be remembered that congenital or acquired syphilis may undoubtedly sometimes play a part in producing the clinical picture of splenic ansemia (in adults) or Banti's disease." In the following case of splenic anemia treatment by neo-salvarsan constituted only part of the arsenical therapy employed, but the result was very good.2
The patient, Mrs. S. A., a pale, dark-skinned Turkish woman, aged .30, was admitted under my care at the German Hospital on October 16, 1912, with chronic enlargemrient of the spleen and a leucopenic type of aneemia. The spleen felt hard and extended downwards to the anterior superior iliac spine and across the middle line, three finger-breadths to the right of the umbilicus. The liver was apparently not enlarged. 'The conjunctivae had a very slightly subicteric tinge. The urine was -of rather high colour, free from bilirubin, but giving a positive reaction for urobilin and urobilinogen. The faeces were well coloured. The patient was said to have been healthy as a child, and up to the time of her marriage (six years ago). Five years ago (after her first confine-I F. Perussia, Minch. med. Wochenschr., 1912 , lix, p. 1482 . See also abstracts bearing on the subject in Folia Hcematologica, Leipz. (Zentral-Organ), 1912, xiii, p. 176, and 1913, xiv, pp. 185 et seq. ment) she suffered from "rheumatic fever." .She had an abortion (in the second mnonth) three and a half years ago. , During the two last years before admission she had suffered from lassitude, and during the last year her menstrual loss had become scanty. Under treatment (with occasional interruptions) by arsenic-nanmely, by Fowler's solution, arsacetin, and finally by intravenous injections of neo-salvarsan-the spleen decidedly diminished in size, the anmemia vanished, the patient gained in body-weight, the menstrual flow increased, and there was a subjective sense of improvement. At the end of January, 1913, the spleen reached only to the middle line and downwards to about the umbilical level. The patient's weight, which was about 7 st. 7 lb. on admission, was then 8 st. 101 lb. The conjunctivt had lost their previously yellowish tinge and the urine no longer gave the reactions for excess of urobilin and for urobilinogen, which were at first present. The injections of neo-salvarsan were three in number: 0 45 grm. on January 13, 0 3 grm. on January 23, and 0'45 grm. on February 8.
Blood examination (Dr. Bauch) on October 21, 1912: Haemoglobin, 35 per cent.; red cells, 3,300,000 to the cubic millimetre of blood; white cells, 1,500. On November 22, 1912 : Haemoglobin, 45 per cent.; red cells, 3,480,000; white cells, 3,950 (of which-lymphocytes, 38'6 per cent.; polymorphonuclear neutrophiles, 52 7 per cent.; monocytes, 4.6 per cent.; eosinophiles, 1-8 per cent.; myelocytes, 2'3 per cent.). On January 7, 1913: Haemoglobin, 55 per cent.; red cells, 3,880,000; white cells, 6,000 (of which-lymphocytes, 41'2 per cent.; polymorphonuclear neutrophiles, 42'8 per cent.; monocytes, 9'2 per cent.; eosinophiles, 6'8 per cent.). On January 27, 1913: Haemoglobin, 65 per cent.; red cells, 5,960,000; white cells, 4,250 (of which -lymphocytes, 60'2 per cent.; polymorphonuclear neutrophiles, 36'5 per cent.; monocytes, 2'2 per cent.; eosinophiles, 11 per cent.; no mast cells). The red cells (in stained blood films), which at first showed anisocytosis, polychromatophilia, and moderate poikilocytosis, appeared normal when examined on January 27. In the stained blood films no nucleated red cells were ever seen, except on October 28, 1912, when one normoblast was noted. There was (January 27) perhaps very slightly increased fragility of the red blood cells as tested by graduated hypotonic saline solutions, partial haemolysis occurring with 0 45 per cent. and complete hoemolysis with 0 4 per cent. aqueous solutions of sodium chloride. The blood plasma (January 27) was of normal yellow colour, transparent, and apparently free from bilirubin. A negative Wassermann's reaction for syphilis was obtained with the patient's blood serum (Lister Institute, October, 1912) . On February 11 the red cells numbered 5,400,000 to the cubic millimetre of blood, and the white cells 4,600; haemoglobin, 75 per cent. The red cells seemed quite normal. On March 13, when I last saw the patient, she looked very well, and the spleen, which seemed not to be very hard, could be felt reaching only two or three finger-breadths below the costal margin.
It is probable that this case would likewise have done well with *other arsenical preparations had not neo-salvarsan been given.
I have not yet used salvarsan or neo-salvarsan in leukeemia, but my -colleague Dr. Karl Fuirth, at the German Hospital, has given neosalvarsan in a typical case of chronic myeloid leukeemia (the old "splenomedullary leucocythaemia "), which I have often seen, and to which he has kindly allowed me to refer. The case was that of a man, aged 50,
.of fairly strong build and only moderately aneemic, but with a count of -364,000 white cells (chiefly polymorphonuclear leucocytes, myelocytes, and myeloblasts) to the cubic millimetre of blood. Two small intravenous injections of neo-salvarsan (0'15 and 0 3 grm. respectively) were followed by considerable febrile reaction, and the blood condition was rather worse than better afterwards. Other methods of treatment were therefore adopted.
I have as yet had no opportunity of trying salvarsan or neo-salvarsan -in a typical case of Hodgkin's disease (lymphoma granulomatosum), but I should very much distrust any rapid results obtained. The disease, notably in adults, usually begins by a decidedly local enlargement of lymphatic glands, the glands on one side of the neck and near the clavicle constituting the group most frequently involved. Under treatment, especially by X-rays and ordinary arsenical preparations, the mass of enlarged glands may rapidly subside, but this apparently good result is often followed by rapid enlargement of intra-abdominal lymphatic glands and by involvement of the spleen and liver, and then by pyrexia, increasing cachexia, and death. In genuine cases of Hodgkin's disease (notably in adults) early local subsidence of the glandular swelling in the neck does not warrant a favourable prognosis. I refer especially to this because salvarsan is already beginning to be tried in Hodgkin's disease, and because I believe that early diminution of a superficial glandular tumour is a pitfall for error in regard to prognosis. I have given salvarsan (or neo-salvarsan) in two cases of malaria with resistant crescent forms of parasites in the blood. The first patient was a German sailor, aged 24, admitted to the hospital in November, 1911, with fever and ordinary intra-corpuscular forms of malarial parasites in his blood. When quinine was given the fever promptly ceased, but extracellular crescent-shaped parasites (which had apparently previously escaped notice) were observed free in his blood. The ordinary intracorpuscular forms had vanished. I then gave him an intravenous injection of original salvarsan (04 grm.), but two days later the crescent forms. were still present in his blood (Dr. G. Dorner). Unfortunately, the patient, as he had no fever and felt well, insisted on leaving the hospital and I lost sight of him. The second patient was a German ship's stoker, aged 25, who in October, 1912 , was admitted to the hospital with fever of the tertian type and some enlargement of the spleen. Many of his red blood cells contained characteristic ordinary intra-corpuscular plasmodia, but there were likewise some free crescent forms present. Quinine treatment promptly removed the fever. I then (October 19) gave him an intravenous injection of neosalvarsan (0'6 grm.) and ordered the quinine to be discontinued. Nine days afterwards (October 28), the temperature suddenly rose to 1050 F., with shivering, and one or two malarial parasites of the small " signetring" type were discovered in the red corpuscles. Two days later, October 30, during a rigor, with fever up to 105'2' F., examination of the blood (Dr. Bauch) showed a great many parasites of similar (small "signet-ring") type. On the following day I injected (intravenously) 0'45 grIll. neo-salvarsan, but on the next day (November 1) there was again a rigor and the temperature reached 104'4' F. Shortly after the rigor the blood was examined and plasmodia of the small " signet-ring" type were again found in the red corpuscles. Two days later (November 3) there was agaAin a rigor, with fever up to 104'60 F. Evidently, therefore, the neo-salvarsan employed had not succeeded, like the quinine had, in checking these "tertian" pyrexial symptoms. Half a gramme of sulphate of quinine was then ordered twice daily and soon checked the fever, which did not return as long as the patient remained under my observation. He left the hospital not very long afterwards (November 14) and the blood was not further examined, but it is obvious that in this case the neo-salvarsan (in the doses employed) had much less effect on the febrile manifestations of the disease than the quinine had.
Salvarsan has apparently been found occasionally useful in troublesome cases of chorea minor,' including one case of chorea gravidarum,2 I See E. Mayerhofer, Wien. klin. Wochenschr., 1911, xxiv, p. 976; J. Salinger, MUlnch. med. Wochenschr., 1912 , lix, p. 1376 L. Szametz, ibid., p. 2333. Weill, Mouriquand, and Goyet (Anin. de med. et de Chirurg. enfant, Par., 1912, xvi, p. 720) claim a good result from rectal injections of salvarsan in severe chorea. and it would be interesting to know if it exercised any favourable action in acute rheumatism; it has, I think, been tried in some cases, but in ordinary acute rheumatism the progress under modern treatment is sufficiently satisfactory to make one hesitate to resort to new methods.
Salvarsan has been employed with benefit in cases of Vincent's sore throat and also in noma.' At present I have under my care at the hospital a young man, aged 18, who was admitted with stomatitis and developed a severe inflammatory infiltration of the right cheek. There is extreme anmmia, and there has s3 far been a leucopenia rather than than a leucocytosis, but he seems to be improving under small intravenous injections of salvarsan.2 Salvarsan has likewise been tried in scarlet fever and other acute febrile infections, and F. Klemperer and H. Woita 3 think that it exercises some genuine specific action in scarlet fever.
In one typical advanced case of disseminated sclerosis, with a negative Wassermann's reaction for syphilis, I tried, in 1911, an intravenous injection of original salvarsan (04 grm.), but apparently without any benefit to the patient, though no disagreeable reaction followed the injection, not even a rise of temperature.
In rebellious cases of chronic lichen planus, and in some cases of pemphigus, it is probable that salvarsan will prove itself useful in the future, but sufficient trials in such cases seem not yet to have been published. In the case of a man, aged 31, who had been subject to urticaria and " giant urticaria " for five years, I last year gave two intravenous injections of -original salvarsan (each of 02 grm.) and one of neo-salvarsan (0'6 grm.). Afterwards he was temporarily free from urticaria and giant urticaria for some time, but that freedom has, unfortunately, not lasted.
Salvarsan and neo-salvarsan have undoubtedly been fairly often tried in cases of malignant diseases (sarcoma and carcinoma), but few results have been published, and probably the results obtained have not been particularly encouraging. I M. Nicoll, jun. (Arch. of Pediatr., New York, 1911, xxviii, p. 912) , records the case of a boy, aged 5, successfully treated with salvarsan (two intravenous injections, each of 0 3 grm.) for noma, after the onset of severe scarlet fever. In Vincent's sore throat local applications of salvarsan solutions have been recommended by some. 2 The improvement did not continue. Examination of the blood showed hardly any haemopoietic reaction, and death occurred on May 5, 1913. The necropsy proved the case to be one of so-called " aplastic " anemia.
8 Klemperer and Woita, 29 Deutsch. Kongress f. inn. Med., April, 1912 , Deutsch. med. Wochenschr., 1912 
